نتائج البحث

Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions.

• Authors : Li, Hongyao^1,2,3 (AUTHOR); Wen, Xiang³ (AUTHOR); Ren, Yueting^3,4 (AUTHOR)

• Source: Molecular Cancer. 8/10/2024, Vol. 23 Issue 1, p1-42. 42p.

تفاصيل العنوان

AR and PI3K Genomic Profiling of Cell-free DNA Can Identify Poor Responders to Lutetium-177-PSMA Among Patients with Metastatic Castration-resistant Prostate Cancer

• Authors : Vanwelkenhuyzen, J; Van Bos, E; Van Bruwaene, S

Subjects: Medicin och hälsovetenskap

• Source: European urology open science. 53:63-66

تفاصيل العنوان

PI3K 信号过度活化引发免疫病理机制研究进展.

• Authors : 王燕^1,2; 周远涛²; 张玉²

• Source: Chinese Journal of Immunology. Jul2024, Vol. 40 Issue 7, p1536-1541. 6p.

تفاصيل العنوان

Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions

• Authors : Hongyao Li; Xiang Wen; Yueting Ren

Subjects: PI3K family; Class I PI3K; Clinical applications

• Source: Molecular Cancer, Vol 23, Iss 1, Pp 1-42 (2024)

تفاصيل العنوان

Integrating Network Pharmacology, Transcriptomics to Reveal Neuroprotective of Curcumin Activate PI3K / AKT Pathway in Parkinson’s Disease

• Authors : Cai B; Wang Q; Zhong L

Subjects: parkinson’s disease; curcumin; network pharmacology

• Source: Drug Design, Development and Therapy, Vol Volume 18, Pp 2869-2881 (2024)

تفاصيل العنوان

真武汤合五皮饮加减对糖尿病肾病患者肾脏纤维化、肾小管氧化损伤和 PI3K/Akt/NF-κB 信号通路的影响.

• Authors : 周丰宝¹ ; 马 群¹

• Source: Evaluation & Analysis of Drug-Use in Hospitals of China. 2024, Vol. 24 Issue 4, p451-458. 5p.

تفاصيل العنوان

Idelalisib (PI3K delta inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients

• Authors : Mattsson, Agnes; Sylvan, Sandra Eketorp; Axelsson, Per

Subjects: CLL; idelalisib; PI3K & delta

• Source: European Journal of Haematology. 111(5):715-721

تفاصيل العنوان

ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells.

• Authors : Wu, Chung-Pu^1,2,3,4 (AUTHOR) ; Hung, Cheng-Yu³ (AUTHOR); Murakami, Megumi⁵ (AUTHOR)

Subjects: *PHOSPHATIDYLINOSITOL 3-kinases; *MITOGEN-activated protein kinases; *CANCER cells

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5160. 11p.

تفاصيل العنوان

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Women With a PI3K Alteration and HR+/Her2- Breast Cancer (Amelia-1)

• Source: Rugo HS, Andre F, Yamashita T, Cerda H, Toledano I, Stemmer SM, Jurado JC, Juric D, Mayer I, Ciruelos EM, Iwata H, Conte P, Campone M, Wilke C, Mills D, Lteif A, Miller M, Gaudenzi F, Loibl S. Time

تفاصيل العنوان

TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway.

• Authors : Gao, Feng^1,2,3 (AUTHOR); Liu, Sichen⁴ (AUTHOR); Wang, Jing¹ (AUTHOR)

• Source: Journal of Experimental & Clinical Cancer Research (17569966). 7/20/2024, Vol. 43 Issue 1, p1-21. 21p.

تفاصيل العنوان